
Sultana Marcia Zalalee
Examiner (ID: 19085, Phone: (571)270-1411 , Office: P/2614 )
| Most Active Art Unit | 2614 |
| Art Unit(s) | 2614, 2619, 2679, 2628 |
| Total Applications | 597 |
| Issued Applications | 417 |
| Pending Applications | 59 |
| Abandoned Applications | 136 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4214284
[patent_doc_number] => 06087162
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Transgenic plants resistant to geminivirus infection'
[patent_app_type] => 1
[patent_app_number] => 8/643779
[patent_app_country] => US
[patent_app_date] => 1996-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7569
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087162.pdf
[firstpage_image] =>[orig_patent_app_number] => 643779
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/643779 | Transgenic plants resistant to geminivirus infection | May 5, 1996 | Issued |
Array
(
[id] => 4358017
[patent_doc_number] => 06168943
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-02
[patent_title] => 'Methods for making modified recombinant vesiculoviruses'
[patent_app_type] => 1
[patent_app_number] => 8/646695
[patent_app_country] => US
[patent_app_date] => 1996-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 26786
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 338
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/168/06168943.pdf
[firstpage_image] =>[orig_patent_app_number] => 646695
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/646695 | Methods for making modified recombinant vesiculoviruses | May 2, 1996 | Issued |
Array
(
[id] => 4345019
[patent_doc_number] => 06290952
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Method of dephosphorylating an endotoxin in vivo with alkaline phosphatase'
[patent_app_type] => 1
[patent_app_number] => 8/596297
[patent_app_country] => US
[patent_app_date] => 1996-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 12189
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/290/06290952.pdf
[firstpage_image] =>[orig_patent_app_number] => 596297
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/596297 | Method of dephosphorylating an endotoxin in vivo with alkaline phosphatase | Apr 9, 1996 | Issued |
| 08/628014 | ROTAVIRUS ENTEROTOXIN NSP4 AND METHODS OF USING SAME | Apr 3, 1996 | Abandoned |
Array
(
[id] => 1541367
[patent_doc_number] => 06372206
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Orally-administered interferon-TAU compositions and methods'
[patent_app_type] => B1
[patent_app_number] => 08/616904
[patent_app_country] => US
[patent_app_date] => 1996-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 12689
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372206.pdf
[firstpage_image] =>[orig_patent_app_number] => 08616904
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/616904 | Orally-administered interferon-TAU compositions and methods | Mar 14, 1996 | Issued |
Array
(
[id] => 4067853
[patent_doc_number] => 05866791
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Modification of lignin synthesis in plants'
[patent_app_type] => 1
[patent_app_number] => 8/613942
[patent_app_country] => US
[patent_app_date] => 1996-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4260
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866791.pdf
[firstpage_image] =>[orig_patent_app_number] => 613942
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/613942 | Modification of lignin synthesis in plants | Mar 12, 1996 | Issued |
Array
(
[id] => 3879623
[patent_doc_number] => 05747648
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Modified wheat glutens and use thereof in fabrication of films'
[patent_app_type] => 1
[patent_app_number] => 8/614373
[patent_app_country] => US
[patent_app_date] => 1996-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3168
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747648.pdf
[firstpage_image] =>[orig_patent_app_number] => 614373
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/614373 | Modified wheat glutens and use thereof in fabrication of films | Mar 11, 1996 | Issued |
Array
(
[id] => 3800726
[patent_doc_number] => 05853747
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-29
[patent_title] => 'Therapeutic and dietetic uses of a brain phospholipid-based complex'
[patent_app_type] => 1
[patent_app_number] => 8/617806
[patent_app_country] => US
[patent_app_date] => 1996-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1963
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/853/05853747.pdf
[firstpage_image] =>[orig_patent_app_number] => 617806
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/617806 | Therapeutic and dietetic uses of a brain phospholipid-based complex | Feb 26, 1996 | Issued |
Array
(
[id] => 3734469
[patent_doc_number] => 05753235
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Recombinant canine herpesviruses'
[patent_app_type] => 1
[patent_app_number] => 8/602010
[patent_app_country] => US
[patent_app_date] => 1996-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26076
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753235.pdf
[firstpage_image] =>[orig_patent_app_number] => 602010
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/602010 | Recombinant canine herpesviruses | Feb 14, 1996 | Issued |
Array
(
[id] => 3996341
[patent_doc_number] => 05919919
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-06
[patent_title] => 'Brassica sp. gene promoter highly expressed during tapetum development'
[patent_app_type] => 1
[patent_app_number] => 8/595937
[patent_app_country] => US
[patent_app_date] => 1996-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 5580
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/919/05919919.pdf
[firstpage_image] =>[orig_patent_app_number] => 595937
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/595937 | Brassica sp. gene promoter highly expressed during tapetum development | Feb 5, 1996 | Issued |
Array
(
[id] => 3821544
[patent_doc_number] => 05783194
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-21
[patent_title] => 'Homogeneous isolate of urabe mumps virus and vaccines containing the isolate'
[patent_app_type] => 1
[patent_app_number] => 8/594295
[patent_app_country] => US
[patent_app_date] => 1996-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8980
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/783/05783194.pdf
[firstpage_image] =>[orig_patent_app_number] => 594295
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/594295 | Homogeneous isolate of urabe mumps virus and vaccines containing the isolate | Jan 29, 1996 | Issued |
Array
(
[id] => 3992924
[patent_doc_number] => 05919705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-06
[patent_title] => 'Plant virus DNA constructs and virus resistant plants comprising said constructs'
[patent_app_type] => 1
[patent_app_number] => 8/553619
[patent_app_country] => US
[patent_app_date] => 1995-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12380
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/919/05919705.pdf
[firstpage_image] =>[orig_patent_app_number] => 553619
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/553619 | Plant virus DNA constructs and virus resistant plants comprising said constructs | Nov 30, 1995 | Issued |
Array
(
[id] => 3759892
[patent_doc_number] => 05741697
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-21
[patent_title] => 'Bacteriophage of chlamydia psittaci'
[patent_app_type] => 1
[patent_app_number] => 8/565386
[patent_app_country] => US
[patent_app_date] => 1995-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7015
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/741/05741697.pdf
[firstpage_image] =>[orig_patent_app_number] => 565386
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/565386 | Bacteriophage of chlamydia psittaci | Nov 29, 1995 | Issued |
Array
(
[id] => 3772220
[patent_doc_number] => 05773599
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => '48 kD cellular phosphoprotein CtBP'
[patent_app_type] => 1
[patent_app_number] => 8/553999
[patent_app_country] => US
[patent_app_date] => 1995-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 4966
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773599.pdf
[firstpage_image] =>[orig_patent_app_number] => 553999
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/553999 | 48 kD cellular phosphoprotein CtBP | Nov 5, 1995 | Issued |
Array
(
[id] => 3950185
[patent_doc_number] => 05935570
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => 'Synthesis of immunologic, therapeutic and prophylactic compounds by transformed clavibacter'
[patent_app_type] => 1
[patent_app_number] => 8/546117
[patent_app_country] => US
[patent_app_date] => 1995-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9919
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/935/05935570.pdf
[firstpage_image] =>[orig_patent_app_number] => 546117
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/546117 | Synthesis of immunologic, therapeutic and prophylactic compounds by transformed clavibacter | Oct 19, 1995 | Issued |
Array
(
[id] => 4196918
[patent_doc_number] => 06013514
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-11
[patent_title] => 'Haemophilus outer membrane protein'
[patent_app_type] => 1
[patent_app_number] => 8/433522
[patent_app_country] => US
[patent_app_date] => 1995-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 82
[patent_figures_cnt] => 18
[patent_no_of_words] => 37180
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/013/06013514.pdf
[firstpage_image] =>[orig_patent_app_number] => 433522
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/433522 | Haemophilus outer membrane protein | Sep 11, 1995 | Issued |
Array
(
[id] => 3936124
[patent_doc_number] => 05981258
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Composition of trans-dominant variants of viral proteins for obtaining an antiviral effect'
[patent_app_type] => 1
[patent_app_number] => 8/505210
[patent_app_country] => US
[patent_app_date] => 1995-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7876
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981258.pdf
[firstpage_image] =>[orig_patent_app_number] => 505210
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/505210 | Composition of trans-dominant variants of viral proteins for obtaining an antiviral effect | Aug 13, 1995 | Issued |
| 08/509914 | MILD NEWCASTLE DISEASE VIRUS VACCINE | Jul 31, 1995 | Abandoned |
Array
(
[id] => 4299718
[patent_doc_number] => 06326007
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Attenuated lentivirus vectors expressing interferon'
[patent_app_type] => 1
[patent_app_number] => 8/504723
[patent_app_country] => US
[patent_app_date] => 1995-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 13544
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326007.pdf
[firstpage_image] =>[orig_patent_app_number] => 504723
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/504723 | Attenuated lentivirus vectors expressing interferon | Jul 19, 1995 | Issued |
| 08/472455 | RECOMBINANT VACCINES TO BREAK SELF-TOLERANCE | Jun 6, 1995 | Abandoned |